Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan-Reference-Cited by-同舟云学术

Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan

Published:2011-05-12 Issue:3 Volume:26 Page:234-245
ISSN:1868-4300
Container-title:Cardiovascular Intervention and Therapeutics
language:en
Short-container-title:Cardiovasc Interv and Ther

Author:

Kimura Takeshi,Morimoto Takeshi,Furukawa Yutaka,Nakagawa Yoshihisa,Kadota Kazushige,Iwabuchi Masashi,Shizuta Satoshi,Shiomi Hiroki,Tada Tomohisa,Tazaki Junichi,Kato Yoshihiro,Hayano Mamoru,Abe Mitsuru,Tamura Takashi,Shirotani Manabu,Miki Shinji,Matsuda Mitsuo,Takahashi Mamoru,Ishii Katsuhisa,Tanaka Masaru,Aoyama Takeshi,Doi Osamu,Hattori Ryuichi,Tatami Ryozo,Suwa Satoru,Takizawa Akinori,Takatsu Yoshiki,Takahashi Masaaki,Kato Hiroshi,Takeda Teruki,Lee Jong-Dae,Nohara Ryuji,Ogawa Hisao,Tei Chuwa,Horie Minoru,Kambara Hirofumi,Fujiwara Hisayoshi,Mitsudo Kazuaki,Nobuyoshi Masakiyo,Kita Toru

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12928-011-0065-0.pdf

Reference21 articles.

1. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–21.

2. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L, SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009–19.

3. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–78.

4. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, BASKET-LATE Investigators, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48:2584–91.

5. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: comparative meta-analysis of randomized trials and observational studies. Circulation. 2009;119:3198–206.

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Effects of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention in High-Risk Subgroups;Circulation Journal;2024-08-06

2. Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation;Journal of Atherosclerosis and Thrombosis;2023-12-01

3. The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention;The American Journal of Cardiology;2023-09

4. Ten‐year clinical outcomes from a randomized trial comparing new‐generation everolimus‐eluting stent versus first‐generation Sirolimus‐eluting stent: Results from the RESET extended study;Catheterization and Cardiovascular Interventions;2023-08-06

5. Sex Differences in Clinical Outcomes After Percutaneous Coronary Intervention;Circulation Journal;2023-01-25